Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaboration to Advance Data Visualization and Discovery Platform

By LabMedica International staff writers
Posted on 02 Oct 2012
PerkinElmer, Inc. More...
(Waltham, MA, USA) and Tibco Software, Inc. (Palo Alto, CA, USA), the provider of Tibco Spotfire, a leading analytics and data discovery platform, announced that they have entered into an exclusive strategic relationship.

Under the terms of this new agreement, PerkinElmer has licensed the exclusive, worldwide rights to the Tibco Spotfire software platform in specific scientific research and development markets. These markets include basic and preclinical development applications in life sciences as well as R&D, quality assurance and quality control applications in chemical, petrochemical, environmental, food and beverage, consumer products, and academia.

This alliance will combine the depth and strength of PerkinElmer’s domain knowledge and systems with the analytic capabilities of Tibco Spotfire to provide a broader, richer set of analytic solutions for the research market. As a result, PerkinElmer will take responsibility for growing and servicing the Tibco Spotfire business in these markets.

“How scientists capture and visualize their data through the Tibco Spotfire platform is fundamental to how scientists conduct their work. Spotfire is a critical data analysis tool for the R&D community and complements PerkinElmer’s informatics offering by adding search and data visualization, which are among the most pressing business requirements of life sciences, diagnostics and environmental laboratories, worldwide,” said Mike Stapleton, general manager of informatics at PerkinElmer. “Through this strategic relationship, we are very excited to offer scientists a complete package of data generation, data management as well as data analysis and visualization to better harness information for more informed insights and decisions. The interoperability of PerkinElmer’s E-Notebook with the Tibco Spotfire platform puts all information in one place for our customers.”

One of the biggest hurdles for scientists now is the volume and diversity of data they need to gather and study to make knowledgeable and informed decisions that impact both research and business intelligence efforts. The Tibco Spotfire platform helps complete the analysis workflow by adding real time data interpretation to existing data generation and assembly tools. The data visualization tool enables researchers to instantly visualize and share data across an enterprise to reveal opportunities, avoid risks, and anticipate trends. This system can be applied to nearly every type of science and can analyze data from virtually any instrument platform.

“This new relationship is exciting news for research scientists. Our relationship with PerkinElmer will enable a broader community to benefit from the Tibco Spotfire platform and will expand the range and depth of applications serving the rapidly evolving needs of scientific research,” said Christian Marcazzo, co-head of global life sciences for Spotfire at Tibco Software Inc.

PerkinElmer is a provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases, and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites that enable customers to create, analyze, and communicate chemical, biologic, and scientific data more effectively. The company reported revenue of approximately USD 1.9 billion in 2011, has approximately 7,000 employees serving customers in more than 150 countries.

Tibco Software is a provider of infrastructure software for companies to use on-premise or as part of cloud computing environments. Tibco Spotfire is the company’s in-memory analytics software for next-generation business intelligence. By offering a visual, interactive experience, Spotfire helps professionals rapidly discover new and actionable insights in information.

Related Links:

PerkinElmer
Tibco



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.